HomeENTO • NASDAQ
add
Entero Therapeutics Inc
Previous close
$0.55
Day range
$0.47 - $0.53
Year range
$0.19 - $2.29
Market cap
2.34M USD
Avg Volume
2.28M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 821.39K | -90.97% |
Net income | -1.26M | -122.62% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -817.74K | 91.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.35K | -98.27% |
Total assets | 85.20M | -6.51% |
Total liabilities | 28.74M | 116.58% |
Total equity | 56.46M | — |
Shares outstanding | 4.77M | — |
Price to book | -0.51 | — |
Return on assets | -2.41% | — |
Return on capital | -3.56% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.26M | -122.62% |
Cash from operations | -818.64K | 78.15% |
Cash from investing | — | — |
Cash from financing | 700.00K | -79.28% |
Net change in cash | -118.64K | 57.61% |
Free cash flow | -173.27K | -6.48% |
About
Founded
2014
Headquarters
Website
Employees
2
